Comparison of two sedative agents in relation to safety in children.
Phase 3
- Conditions
- Health Condition 1: - Health Condition 2: 3- Administration
- Registration Number
- CTRI/2019/09/021381
- Lead Sponsor
- eethu Ann Preethy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Anxious children requiring pulp therapy
Exclusion Criteria
respiratory disorders, previous medication with erythromycin and/or anticonvulsant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method onset of sedation <br/ ><br>level of sedation <br/ ><br>physiological parameters at different stages of the procedure <br/ ><br>safety scale <br/ ><br>recovery timeTimepoint: Starting at the beginning of the sedation procedure till the end of the sedation procedure,vitals will be monitored- approximately 30 to 45 minutes depending on the severity of the case
- Secondary Outcome Measures
Name Time Method Recovery timeTimepoint: at the end of the sedation procedure i.e., after 30 to 45 from the start of the procedure